$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Orally administered drug composition for therapy in the treatment of narcotic drug addiction 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/135
출원번호 US-0544360 (1975-01-27)
발명자 / 주소
  • Shaw Irving F. (East Rockaway NY) Berk Jerome (New Rochelle NY)
출원인 / 주소
  • West Laboratories, Inc. (Long Island City NY 02)
인용정보 피인용 횟수 : 187  인용 특허 : 0

초록

Drugs which are suitable for such therapy in treatment of narcotic drug addiction by oral use, e.g., methadone, are formulated to prevent injection abuse through concentration of the active component in aqueous solution by incorporating in a solid dosage or tablet form of such drug an ingestible sol

대표청구항

A solid composition for the oral treatment of narcotic addiction which is dispersible for dissolution before ingestion, said composition comprising: a. an efFective amount of methadone or its acid salts, and b. an ingestible solid in a weight ratio of 10:1 to 40:1 per part of methadone in an amount

이 특허를 인용한 특허 (187)

  1. Raman, Siva N.; Park, Jae Han; Battu, Sunil K.; Burge, Eric A.; Bogan, David W., Abuse deterrent solid dosage form for immediate release with functional score.
  2. Rekhi, Gurvinder S.; Sidwell, Richard, Abuse resistant pharmaceutical compositions.
  3. Rekhi, Gurvinder Singh; Sidwell, Richard, Abuse resistant pharmaceutical compositions.
  4. Rekhi, Gurvinder Singh; Sidwell, Richard, Abuse resistant pharmaceutical compositions.
  5. Rekhi, Gurvinder Singh; Sidwell, Richard, Abuse resistant pharmaceutical compositions.
  6. Rekhi, Gurvinder Singh; Sidwell, Richard, Abuse resistant pharmaceutical compositions.
  7. Bastin Richard James,GBX ; Lithgow Bruce Hamilton,GBX, Abuse resistant tablets.
  8. Guido, Debora L; Huang, Haiyong, Abuse-deterrent dosage forms.
  9. Hirsh, Jane C.; Fleming, Alison B.; Rariy, Roman V.; Klibanov, Alexander M., Abuse-deterrent drug formulations.
  10. Hirsh, Jane; Fleming, Alison; Rariy, Roman; Kilbanov, Alexander, Abuse-deterrent drug formulations.
  11. Hirsh, Jane; Fleming, Alison; Rariy, Roman; Klibanov, Alexander, Abuse-deterrent drug formulations.
  12. Hirsh, Jane; Fleming, Alison; Rariy, Roman; Klibanov, Alexander M., Abuse-deterrent drug formulations.
  13. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  14. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  15. Hirsh, Jane; Klibanov, Alexander M.; Swager, Timothy M.; Buchwald, Stephen L.; Lo, Whe Yong; Fleming, Alison; Rariy, Roman V., Abuse-deterrent pharmaceutical compositions of opiods and other drugs.
  16. Hirsh,Jane; Kibanov,Alexander M.; Swager,Timothy M.; Buchwald,Stephen L.; Lo,Whe Yong; Fleming,Alison B.; Rariy,Roman V., Abuse-deterrent pharmaceutical compositions of opiods and other drugs.
  17. Rariy, Roman V.; Fleming, Alison B.; Hirsh, Jane; Klibanov, Alexander M., Abuse-deterrent pharmaceutical compositions of opioids and other drugs.
  18. Rariy, Roman V.; Fleming, Alison B.; Hirsh, Jane; Klibanov, Alexander M., Abuse-deterrent pharmaceutical compositions of opioids and other drugs.
  19. Rariy, Roman V.; Fleming, Alison B.; Hirsh, Jane; Klibanov, Alexander M., Abuse-deterrent pharmaceutical compositions of opioids and other drugs.
  20. Arkenau-Maric, Elisabeth; Bartholomaus, Johannes; Kugelmann, Heinrich, Abuse-proof dosage form.
  21. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  22. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  23. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  24. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  25. Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  26. Bartholomaus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  27. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  28. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  29. Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage system.
  30. Rose Jed R. ; Levin Edward D., Agonist-antagonist combination to reduce the use of nicotine and other drugs.
  31. Odidi, Isa, Compositions and methods for reducing overdose.
  32. Odidi, Isa, Compositions and methods for reducing overdose.
  33. Odidi, Isa, Compositions and methods for reducing overdose.
  34. Odidi, Isa, Compositions and methods for reducing overdose.
  35. Arkenau-Marić, Elisabeth; Bartholomaeus, Johannes; Ziegler, Iris; Haupts, Marcel, Dosage form with impeded abuse.
  36. Soscia, Anthony Edward; Peng, Yingxu; Sun, Yichun; Johnson, James R.; Shukla, Atul J., Dosage forms for tamper prone therapeutic agents.
  37. Soscia, Anthony Edward; Peng, Yingxu; Sun, Yichun; Johnson, James R.; Shukla, Atul J., Dosage forms for tamper prone therapeutic agents.
  38. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  39. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  40. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  41. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  42. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  43. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  44. Hoffmeister ; Friedrich ; Hiltmann ; Rudolf ; Wollweber ; Hartmund ; Kr amer ; Helmut, Enteral pharmaceutical compositions.
  45. Jain, Rita I.; Best, Andrea E.; Lockhart, Earle; Marx, Steven E.; Thomas, James W.; Vo, Pamela Giang, Extended release hydrocodone acetaminophen and related methods and uses thereof.
  46. Barnscheid, Lutz; Galia, Eric, Hot-melt extruded pharmaceutical dosage form.
  47. Raman, Siva N.; Park, Jae Han; Diezi, Thomas A.; Herman, Clifford J.; Battu, Sunil K.; Burge, Eric A., Immediate release, abuse deterrent pharmaceutical compositions.
  48. Erickson Victor (c/o George Spector ; 3615 Woolworth Bldg. ; 233 Broadway New York NY 10007) Spector George (3615 Woolworth Bldg. ; 233 Broadway New York NY 10007), Medication dispenser.
  49. Eswara Amruta R. ; Muni Neal ; Schneider F. Howard ; Mione Peter J., Methods and articles of manufacture for nicotine cessation and monitoring nicotine use.
  50. Guido, Debora; Huang, Haiyong Hugh, Methods of preparing tamper resistant pharmaceutical formulations.
  51. Sackler, Richard S., Methods of preparing tamper resistant solid oral dosage forms.
  52. Babul, Najib, Methods of preventing the serotonin syndrome and compositions for use thereof.
  53. Legrand, Valérie; Castan, Catherine; Meyrueix, Rémi; Soula, Gérard, Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles.
  54. Babul, Najib, Multimodal abuse resistant and extended release opioid formulations.
  55. Barnscheid, Lutz; Wening, Klaus; Pätz, Jana; Geissler, Anja, Multiparticles safeguarded against ethanolic dose-dumping.
  56. Vinson, Robert; Gosselin, Patrick; Betancourt, Aimesther Ojito, Narcotic drug formulations with decreased abuse potential.
  57. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  58. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  59. Castan, Catherine; Guimberteau, Florence; Meyrueix, Rémi, Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s).
  60. Castan, Catherine; Guimberteau, Florence; Meyrueix, Rémi, Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s).
  61. Barnscheid, Lutz; Galia, Eric; Schwier, Sebastian; Bertram, Ulrike; Geissler, Anja; Griessmann, Kornelia; Bartholomäus, Johannes, Oxidation-stabilized tamper-resistant dosage form.
  62. Kao, Haui-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  63. Kao, Huai-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  64. Liang, Alfred; Matthews, Frank; Boehm, Garth; Tang, Lijuan; Johnson, Frank; Stauffer, Joseph, Pharmaceutical composition.
  65. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical composition.
  66. Mayo Alvarez,Ricardo; McNeil,Ronny, Pharmaceutical composition.
  67. Mayo-Alvarez, Ricardo; McNeil, Ronny, Pharmaceutical composition.
  68. Mayo-Alvarez, Ricardo; McNeil, Ronny, Pharmaceutical composition.
  69. Mayo-Alvarez, Ricardo; McNeil, Ronny, Pharmaceutical composition.
  70. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical composition containing gelling agent.
  71. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions.
  72. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions for the deterrence and/or prevention of abuse.
  73. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Ziegler, Iris; Schüssele, Andrea, Pharmaceutical dosage form.
  74. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Ziegler, Iris; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Schüessele, Andrea, Pharmaceutical dosage form.
  75. Sackler, Richard, Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent.
  76. Gruber,Thomas, Pharmaceutical formulation containing dye.
  77. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  78. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  79. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  80. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  81. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  82. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  83. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  84. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  85. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  86. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  87. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  88. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  89. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  90. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  91. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  92. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  93. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  94. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  95. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  96. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  97. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  98. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  99. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  100. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  101. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  102. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  103. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  104. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  105. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  106. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  107. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  108. Sackler, Richard, Pharmaceutical formulation containing irritant.
  109. Sackler, Richard, Pharmaceutical formulation containing irritant.
  110. Sackler, Richard, Pharmaceutical formulation containing irritant.
  111. Sackler, Richard, Pharmaceutical formulation containing irritant.
  112. Oshlack, Benjamin; Wright, Curtis; Breder, Christopher, Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent.
  113. Oshlack, Benjamin; Wright, Curtis; Breder, Christopher, Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent.
  114. Oshlack, Benjamin; Wright, Curtis; Breder, Christopher, Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent.
  115. Oshlack, Benjamin; Wright, Curtis; Breder, Christopher, Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent.
  116. Sackler,Richard, Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant.
  117. Sackler, Richard, Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent.
  118. Sackler, Richard, Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent.
  119. Sackler, Richard, Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent.
  120. Sackler, Richard, Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent.
  121. Powell David R. (Baudette MN) Patel Vithal K. (Baudette MN), Pharmaceutical formulation for slow release via controlled surface erosion.
  122. Hughes, Lyn, Pharmaceutical formulation including a resinate and an aversive agent.
  123. Oshlack, Benjamin; Wright, Curtis; Breder, Christopher, Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent.
  124. Haupts, Marcel, Preparation of a powdery pharmaceutical composition by means of an extruder.
  125. Faure, Anne; Voorspoels, Jody Firim Marceline; Mertens, Roel Jos M.; Kiekens, Filip René Irena, Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet.
  126. Arkenau, Elisabeth; Bartholomāus, Johannes, Process for the production of an abuse-proofed solid dosage form.
  127. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Process for the production of an abuse-proofed solid dosage form.
  128. Saim, Said; Fleming, Alison B.; Varanasi, Ravi K., Process of making stable abuse-deterrent oral formulations.
  129. Saim, Said; Fleming, Alison B.; Varanasi, Ravi K., Process of making stable abuse-deterrent oral formulations.
  130. Saim, Said; Fleming, Alison B.; Varanasi, Ravi K., Process of making stable abuse-deterrent oral formulations.
  131. Guimberteau, Florence; Dargelas, Frederic, Prolonged-release multimicroparticulate oral pharmaceutical form.
  132. Boehm, Garth, Sequestering subunit and related compositions and methods.
  133. Boehm, Garth, Sequestering subunit and related compositions and methods.
  134. Myers, Garry L.; Hilbert, Samuel D.; Boone, Bill J.; Bogue, Beuford Arlie; Sanghvi, Pradeep; Hariharan, Madhusudan, Sublingual and buccal film compositions.
  135. Baichwal,Anand R.; Kao,Huai Hung; McCall,Troy W., Sustained release formulations of oxymorphone.
  136. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  137. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  138. Barnscheid, Lutz; Schwier, Sebastian; Bartholomäus, Johannes, Tamper resistant dosage form comprising an anionic polymer.
  139. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Strauch, Stefanie; Pätz, Jana; Schwier, Sebastian, Tamper resistant dosage form with bimodal release profile.
  140. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  141. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  142. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  143. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  144. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  145. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  146. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  147. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  148. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  149. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  150. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  151. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  152. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  153. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  154. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  155. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  156. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  157. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  158. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  159. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  160. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  161. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  162. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  163. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  164. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  165. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  166. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  167. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  168. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  169. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  170. Friedrich, Ingo; Fuhrherr, Richard; Möschter, Silke; Wengner, Simone, Tamper resistant immediate release capsule formulation comprising tapentadol.
  171. Bausch, James M.; Kershman, Alvin; Shear, Jeff L.; Lewis, Linda L., Tamper resistant lipid-based oral dosage form for opioid agonists.
  172. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  173. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  174. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  175. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  176. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  177. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  178. Sackler, Richard S., Tamper resistant solid oral dosage forms.
  179. Barnscheid, Lutz; Redmer, Jessica; Schwier, Sebastian, Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer.
  180. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Pätz, Jana, Tamper-resistant dosage form containing one or more particles.
  181. Wening, Klaus; Geiβler, Anja; Denker, Jana; Barnscheid, Lutz, Tamper-resistant dosage form with immediate release and resistance against solvent extraction.
  182. Rariy, Roman V.; Fleming, Alison B.; Hirsh, Jane C.; Saim, Said; Varanasi, Ravi K., Tamper-resistant pharmaceutical compositions of opioids and other drugs.
  183. Rariy, Roman V.; Fleming, Alison; Hirsh, Jane C.; Saim, Said; Varanasi, Ravi K., Tamper-resistant pharmaceutical compositions of opioids and other drugs.
  184. Rariy, Roman; Fleming, Alison; Hirsh, Jane C.; Saim, Said; Varanasi, Ravi K., Tamper-resistant pharmaceutical compositions of opioids and other drugs.
  185. Schwier, Sebastian; Haupts, Marcel; Barnscheid, Lutz; Pätz, Jana, Tamper-resistant tablet providing immediate drug release.
  186. Martin Frederick H. (West Chazy NY) Tsuk Andrew G. (Plattsburgh NY), Therapeutic compositions with enhanced bioavailability.
  187. Barnscheid, Lutz; Galia, Eric; Geißler, Anja; Pätz, Jana; Schwier, Sebastian; Baronsky-Probst, Julia, Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로